Login / Register The Most Trusted Name in Medical Education

Cardiology

Look no further for the most cutting edge cardiology CME courses. We offer cardiology continuing medical education courses in dyslipidemia, acute coronary syndrome (acs), and Morquio A Syndrome, among others.

Elsevier LSD Exchange 2018 02 Web 116x142

Focus on Lysosomal Diseases: New Frontiers for Accelerating Diagnosis and Optimizing Treatment

Format: Webcast

This webcast is based on a roundtable discussion on the optimal diagnosis and future management of lysosomal diseases. Three experts specializing in Fabry, Gaucher, and Pompe disease will raise key clinical questions and discuss how to overcome barriers in daily clinical practice across the lysosomal disease spectrum. The experts will provide an update on the long-term effects of ERT and highlight the remaining challenges, including the consequences of delayed diagnosis. They will discuss the role and importance of early diagnosis and treatment initiation, and provide perspectives on the recent advances in screening programs for newborn and high-risk populations. Lastly, the experts will address the position of emerging therapies and strategies for the optimal management of lysosomal diseases. 

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
910737 116x140 edit

RAISING THE BAR BY LOWERING THE TARGET Integrating PCSK9 Inhibitors into Hypercholesterolemia Management

Format: Resource Center

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia.

During these quick-hitting activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholesterol (LDL-C) levels using nonstatin lipid-lowering medications, including inhibitors of the enzyme protein convertase subtilisin/kexin type 9 (PCSK9). Physicians can complete all 7 video modules for a total of 2.0 AMA PRA Category 1 Credits™. 

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module
Elsevier LSD Exchange 2018 02 Web 116x140 thumbnail 1

The Fabry Exchange: Optimizing Diagnosis and Treatment Initiation

Format: Webcast

This webcast was recorded during a live symposium at the WORLDSymposium Meeting in San Diego, CA, USA, on February 7, 2018. During the symposium, experts from around the world discussed the key clinical questions and controversies in the diagnosis of Fabry disease and the future direction of clinical management. They also addressed the consequences of delayed diagnosis and treatment initiation, provided guidance on understanding available diagnostic options, and discussed genotype–phenotype correlations and their significance for daily clinical practice.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™